Document is current
Any future updates will be listed below
-
Authors
Elorbany, Samar https://orcid.org/0000-0001-8342-0948
Berlato, Chiara
Carnevalli, Larissa S.
Maniati, Eleni https://orcid.org/0000-0001-6993-9890
Barry, Simon T. https://orcid.org/0000-0002-8511-0588
Wang, Jun
Manchanda, Ranjit https://orcid.org/0000-0003-3381-5057
Kzhyshkowska, Julia
Balkwill, Frances https://orcid.org/0000-0002-5587-9759
-
Funding
Funding for this research was provided by:
Wellbeing of Women (ELS960, RTF1013)
Cancer Research UK (A25714, A25714, A18066, A25714)
Tomsk State University (Priority 20-30)
RCUK | Engineering and Physical Sciences Research Council (EP/X028704/1)
- License Information
-
More Information
Article History
Received: 11 April 2024
Accepted: 1 November 2024
First Online: 22 November 2024
Competing interests
: S.E., C.B., E.M., J.W. and J.K. declare no conflict of interest. L.C. and S.B. are paid employees of AstraZeneca. R.M. declares honorarium for advisory board membership from Astrazeneca, MSD and EGL. F.B. is on the Scientific Advisory Board of iOmx Therapeutics AG and has received honoraria from GSK.
